Comparison of molecular assays for detection and typing of human papillomavirus

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 2, 2008, Pages 144.e1-144.e6

  Koidl, Christoph ^a   Bozic, Michael ^a   Hadzisejdic, Ita ^b   Grahovac, Maja ^c   Grahovac, Blazenka ^b   Kranewitter, Wolfgang ^d   Marth, Egon ^a   Kessler, Harald H ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c KBC Zagreb   (Croatia)

^d KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

DNA extraction; human papillomavirus; microarray; polymerase chain reaction; typing

Indexed keywords

DNA POLYMERASE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; LABORATORY TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; WART VIRUS;

EID: 47949103142     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.03.005     Document Type: Article

References (16)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
2. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 1-3
3. Einstein M.H., and Goldberg G.L. Human papillomavirus and cervical neoplasia. Cancer Invest 20 (2002) 1080-1085
4. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
5. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 827-841
6. Fahey M.T., Irwig L., and Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 141 (1995) 680-689
7. Bernstein S.J., Sanchez-Ramos L., and Ndubisi B. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic sample diagnosis and sample adequacy. Am J Obstet Gynecol 185 (2001) 308-317
8. Castle P.E., Sadorra M., Garcia F., Holladay E.B., and Kornegay J. A pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol 44 (2006) 3915-3917
9. Berkhof J., de Bruijne M.C., Zielinski G.D., et al. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyscakaryosis. Int J Cancer 118 (2006) 1759-1768
10. Munoz N., Bosch F.X., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
11. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2 (2002) 342-350
12. Giuliani L., Coletti A., Syrjanen K., Favalli C., and Ciotti M. Comparison of DNA sequencing and Roche Linear Array in human papillomavirus (HPV) genotyping. Anticancer Res 26 (2006) 3939-3941
13. Monsonego J., Bohbot J.M., Pollini G., et al. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol 99 (2005) 160-168
14. Sandri M.T., Lentati P., Benini E., et al. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol 44 (2006) 2141-2146
15. Stevens M.P., Rudland E., Garland S.M., and Tabrizi S.N. Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV test. J Clin Microbiol 44 (2006) 2428-2433
16. Stöcher M., Leb V., Holzl G., and Berg J. A simple approach to the generation of heterologous competitive internal controls for real-time PCR assays on the LightCycler. J Clin Virol 25 (2002) 47-53